Alexis N Lopez
Clinical Assistant Professor

Available to mentor
Alexis N Lopez
Clinical Assistant Professor
  • Recent Publications
    • Recent Publications See All Publications
    • Journal Article
      Quality and safety in the literature: September 2021.
      Lopez A, Gupta A, Houchens N. BMJ Qual Saf, 2021 Sep; 30 (9): 764 - 768. DOI:10.1136/bmjqs-2021-013891
      PMID: 34230115
    • Journal Article
      Quality & safety in the literature: September 2021
      Lopez A, Gupta A, Houchens N. BMJ Quality and Safety, 2021 Sep; 30 (9): 764 - 768. DOI:10.1136/bmjqs-2021-013891
    • Journal Article
      Discontinuation of Warfarin Therapy for Patients With Atrial Fibrillation: The Michigan Anticoagulation Quality Improvement Initiative Experience.
      Barnes GD, Kaatz S, Lopez A, Gu X, Kozlowski J, Krol GD, Froehlich JB. JAMA Cardiol, 2017 Mar 1; 2 (3): 341 - 343. DOI:10.1001/jamacardio.2016.5041
      PMID: 28052153
    • Journal Article
      The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot.
      Mata IF, Davis MY, Lopez AN, Dorschner MO, Martinez E, Yearout D, Cholerton BA, Hu S-C, Edwards KL, Bird TD, Zabetian CP. Am J Med Genet B Neuropsychiatr Genet, 2017 Jan; 174 (1): 113 DOI:10.1002/ajmg.b.32510
      PMID: 27943640
    • Journal Article
      The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot.
      Mata IF, Davis MY, Lopez AN, Dorschner MO, Martinez E, Yearout D, Cholerton BA, Hu S-C, Edwards KL, Bird TD, Zabetian CP. Am J Med Genet B Neuropsychiatr Genet, 2016 Oct; 171 (7): 925 - 930. DOI:10.1002/ajmg.b.32452
      PMID: 27111571
    • Journal Article
      In The Literature
      Grant JF, Saul D, Lopez AN, Hart AL, McQuillan MA. The Hospitalist, 2014 Jun; June:
    • Presentation
      Warfarin Persistence in Atrial Fibrillation
      2013 May 1;
    • Presentation
      Safety concerns in the ED to IM hand-off process
      2012 Mar 1;